Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with one of the following blood cancers: Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal B-Cell Lymphoma (PMBCL), Mantle Cell Lymphoma (MCL), or Follicular Lymphoma (FL), and whose treating doctor has determined them eligible for a type of treatment called CAR-T therapy using a commercially available product in Italy.
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 02 2390 2950
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of the CAR-T cells treatment in lymphomas in the italian real life practice; Efficacy of the CAR-T cells treatment in lymphomas in the italian real life practice
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.